Functional effects of ion channel mutations found via exome sequencing
通过外显子组测序发现离子通道突变的功能影响
基本信息
- 批准号:9193444
- 负责人:
- 金额:$ 26.12万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-08-01 至 2020-07-31
- 项目状态:已结题
- 来源:
- 关键词:AMPA ReceptorsAccountingAcuteAgonistAlgorithmsAmino Acid SubstitutionAmino AcidsArchivesBiological AssayBiotinylationBrainBudgetsCandidate Disease GeneCell surfaceCellsClinicClinicalCodon NucleotidesCollaborationsCommunicationCommunitiesComplementary DNAComplexComputing MethodologiesConsultationsDNADNA Sequence AlterationDataDatabasesDiseaseElectrodesEquilibriumEvaluationExplosionFamilyFunding OpportunitiesFutureGene FamilyGenesGenomic DNAGenomicsGlutamate ReceptorGoalsGrantHumanIndividualInternetIon ChannelKainic Acid ReceptorsLaboratoriesLigandsLiteratureMeasuresMediatingMembrane ProteinsMissense MutationMonoclonal Antibody R24MutagenesisMutationN-Methyl-D-Aspartate ReceptorsNeurologicNeuronsOocytesOutcome MeasurePatientsPhenotypePlayPropertyProteinsProtocols documentationPublicationsReaction TimeReceptor GeneReporterResearch PersonnelResourcesRoleSeizuresServicesSignal TransductionSite-Directed MutagenesisSurfaceSymptomsSystemTestingUnited States National Institutes of HealthVariantWestern BlottingWorkbasebeta-Lactamaseexomeexome sequencinggenetic analysisgenome sequencinggenomic datainsightinterestmutantnervous system disordernovelpatch clampprotein functionprotein structurerare variantreceptorresearch studyresponsetraffickingvoltage clamp
项目摘要
Genomic analysis of patients with neurological conditions is becoming increasingly more common, providing a great deal of genomic data relating changes in patient DNA to neurological disease. However, the rate at which genetic mutations are identified has not been matched by advances in understanding the functional effects of these mutations on target proteins. For most genes, known disease-associated missense mutations far outnumber mutations for which functional data exists. Thus, a large gulf exists between the mutations we know about and our understanding of how individual mutations impact protein function. This gulf is growing wider with the accelerating pace of sequencing. While computational methods exist that predict which missense mutations may be harmful, these algorithms are a poor substitute for functional data. Thus, there is a critical need for a means by which clinically-oriented laboratories can obtain functional insight into the effects of mutations. This R24 proposal seeks to fill the gap between mutations and function for the ligand-gated glutamate receptor gene family, which includes AMPA, kainate, and NMDA receptors encoded by GRIA, GRIK, and GRIN genes, respectively. The decision to focus efforts on one gene family was made in consultation with NIH, and was driven by the budget for this funding opportunity. The number of known mutations in this family of genes encoding NMDA receptor subunits is growing at a fast pace, with well over a hundred novel disease- associated mutations described in just the past 18 months, and many more known but unpublished. Thus, while we will focus on all glutamate receptor mutations, we expect most mutations identified will be in the GRIN family. Interested investigators with glutamate receptor mutations will share the amino acid change, which will be introduced into commercial cDNAs for use in heterologous expressions systems to obtain functional data describing the effects of the mutation. The Resource Center will share this functional information with the clinical lab, and work to facilitate publication of the data. This effort will fill a critical gap in the literature, advance our understanding of neurological disease, and provide new ideas about future treatment paradigms. Three activities will be supported by this R24 resource grant. First, we will contact at least 100 laboratories performing whole exome/genome sequencing to inform them of this resource. Second, for clinics or investigators who have identified GRIN mutations and would like to obtain functional analysis, we will introduce the mutation into commercially available human cDNAs and functionally evaluate the effects of the mutation on agonist potency, modulator sensitivity, response time course, and receptor surface expression. Third, we will develop a searchable database on the web to archive results from this project, and connect our results with several existing databases (ClinVar, EGI, etc.).
对神经系统疾病患者的基因组分析变得越来越普遍,提供了大量将患者 DNA 变化与神经系统疾病相关的基因组数据。然而,基因突变的识别速度与了解这些突变对靶蛋白功能影响的进展并不匹配。对于大多数基因来说,已知的与疾病相关的错义突变数量远远多于现有功能数据的突变数量。因此,我们所了解的突变与我们对单个突变如何影响蛋白质功能的理解之间存在着巨大的鸿沟。随着测序步伐的加快,这种鸿沟正在变得越来越大。虽然存在预测哪些错义突变可能有害的计算方法,但这些算法并不能很好地替代功能数据。因此,迫切需要一种方法,使临床实验室能够获得对突变影响的功能性洞察。该 R24 提案旨在填补配体门控谷氨酸受体基因家族的突变和功能之间的空白,该家族包括分别由 GRIA、GRIK 和 GRIN 基因编码的 AMPA、红藻氨酸和 NMDA 受体。将重点放在一个基因家族上的决定是与 NIH 协商后做出的,并受到这一资助机会预算的推动。该编码 NMDA 受体亚基的基因家族中的已知突变数量正在快速增长,仅在过去 18 个月内就描述了超过 100 个与疾病相关的新突变,还有更多已知但未发表的突变。因此,虽然我们将重点关注所有谷氨酸受体突变,但我们预计大多数已识别的突变将出现在 GRIN 家族中。对谷氨酸受体突变感兴趣的研究人员将分享氨基酸的变化,这些变化将被引入商业cDNA中,用于异源表达系统,以获得描述突变影响的功能数据。资源中心将与临床实验室共享这些功能信息,并努力促进数据的发布。这项工作将填补文献中的一个关键空白,增进我们对神经系统疾病的理解,并为未来的治疗范式提供新的想法。 R24 资源赠款将支持三项活动。首先,我们将联系至少 100 个进行全外显子组/基因组测序的实验室,向他们通报这一资源。其次,对于已经识别出 GRIN 突变并希望获得功能分析的诊所或研究人员,我们将将该突变引入市售的人类 cDNA 中,并从功能上评估该突变对激动剂效力、调节剂敏感性、反应时程和受体的影响表面表达。第三,我们将在网络上开发一个可搜索的数据库来存档该项目的结果,并将我们的结果与几个现有数据库(ClinVar、EGI 等)连接起来。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Stephen F Traynelis其他文献
Stephen F Traynelis的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Stephen F Traynelis', 18)}}的其他基金
Genetic analysis to determine the functional role of GRID1
遗传分析以确定 GRID1 的功能作用
- 批准号:
10217304 - 财政年份:2021
- 资助金额:
$ 26.12万 - 项目类别:
Glutamate receptors and human neurological disease
谷氨酸受体与人类神经系统疾病
- 批准号:
10392917 - 财政年份:2019
- 资助金额:
$ 26.12万 - 项目类别:
Glutamate receptors and human neurological disease
谷氨酸受体与人类神经系统疾病
- 批准号:
10153899 - 财政年份:2019
- 资助金额:
$ 26.12万 - 项目类别:
Glutamate receptors and human neurological disease
谷氨酸受体与人类神经系统疾病
- 批准号:
9923776 - 财政年份:2019
- 资助金额:
$ 26.12万 - 项目类别:
Glutamate receptors and human neurological disease
谷氨酸受体与人类神经系统疾病
- 批准号:
10608949 - 财政年份:2019
- 资助金额:
$ 26.12万 - 项目类别:
Control of AMPA receptor function by phosphorylation
通过磷酸化控制 AMPA 受体功能
- 批准号:
8415573 - 财政年份:2010
- 资助金额:
$ 26.12万 - 项目类别:
Control of AMPA receptor function by phosphorylation
通过磷酸化控制 AMPA 受体功能
- 批准号:
8015207 - 财政年份:2010
- 资助金额:
$ 26.12万 - 项目类别:
Control of AMPA receptor function by phosphorylation
通过磷酸化控制 AMPA 受体功能
- 批准号:
8213435 - 财政年份:2010
- 资助金额:
$ 26.12万 - 项目类别:
相似国自然基金
套期会计有效性的研究:实证检验及影响机制
- 批准号:72302225
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
上市公司所得税会计信息公开披露的经济后果研究——基于“会计利润与所得税费用调整过程”披露的检验
- 批准号:72372025
- 批准年份:2023
- 资助金额:40 万元
- 项目类别:面上项目
全生命周期视域的会计师事务所分所一体化治理与审计风险控制研究
- 批准号:72372064
- 批准年份:2023
- 资助金额:40 万元
- 项目类别:面上项目
兔死狐悲——会计师事务所同侪CPA死亡的审计经济后果研究
- 批准号:72302197
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
环境治理目标下的公司财务、会计和审计行为研究
- 批准号:72332003
- 批准年份:2023
- 资助金额:166 万元
- 项目类别:重点项目
相似海外基金
Therapeutic Efficacy of Ketamine Metabolites for Depression Treatment
氯胺酮代谢物治疗抑郁症的疗效
- 批准号:
9314708 - 财政年份:2016
- 资助金额:
$ 26.12万 - 项目类别:
MicroRNA101 and the Termination of Early Phase Neural Development
MicroRNA101 与早期神经发育的终止
- 批准号:
8823230 - 财政年份:2014
- 资助金额:
$ 26.12万 - 项目类别:
MicroRNA101 and the Termination of Early Phase Neural Development
MicroRNA101 与早期神经发育的终止
- 批准号:
8914061 - 财政年份:2014
- 资助金额:
$ 26.12万 - 项目类别:
PI(3,5)P2 synthesis in AMPA receptor trafficking and synaptic function
AMPA 受体运输和突触功能中的 PI(3,5)P2 合成
- 批准号:
8202383 - 财政年份:2011
- 资助金额:
$ 26.12万 - 项目类别:
PI(3,5)P2 synthesis in AMPA receptor trafficking and synaptic function
AMPA 受体运输和突触功能中的 PI(3,5)P2 合成
- 批准号:
8465947 - 财政年份:2011
- 资助金额:
$ 26.12万 - 项目类别: